Pierre Gravier

Insider Reports History

Location
South Plainfield, NJ
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pierre Gravier:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PTC THERAPEUTICS, INC. CHIEF FINANCIAL OFFICER Common Stock 71.9K $3.56M $49.46 15 Jul 2025 Direct
PTC THERAPEUTICS, INC. CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 56.3K $1.52M $27.05 03 Jan 2025 Direct
CASSAVA SCIENCES INC Director Stock Option (Right to Buy) 26.5K $169K $16.87 23 May 2025 Direct

Insider Reports Filed by Pierre Gravier

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PTCT PTC THERAPEUTICS, INC. 15 Jul 2025 1 -$124K 4 CHIEF FINANCIAL OFFICER 17 Jul 2025, 17:20
SAVA CASSAVA SCIENCES INC 23 May 2025 1 $0 4 Director 27 May 2025, 16:23
PTCT PTC THERAPEUTICS, INC. 19 Feb 2025 2 -$117K 4 CHIEF FINANCIAL OFFICER 21 Feb 2025, 17:20
PTCT PTC THERAPEUTICS, INC. 03 Jan 2025 2 $0 4 CHIEF FINANCIAL OFFICER 07 Jan 2025, 17:20
PTCT PTC THERAPEUTICS, INC. 16 Jul 2024 1 -$77.2K 4 CHIEF FINANCIAL OFFICER 18 Jul 2024, 17:20
SAVA CASSAVA SCIENCES INC 09 May 2024 1 $0 4 Director 13 May 2024, 16:11
PTCT PTC THERAPEUTICS, INC. 15 Feb 2024 3 $0 4 CHIEF FINANCIAL OFFICER 16 Feb 2024, 16:11
PTCT PTC THERAPEUTICS, INC. 12 Dec 2023 1 $199K 4 CHIEF FINANCIAL OFFICER 14 Dec 2023, 16:38
SAVA CASSAVA SCIENCES INC 06 Dec 2023 1 $0 4 Director 07 Dec 2023, 16:57
SAVA CASSAVA SCIENCES INC 06 Dec 2023 0 $0 3 Director 07 Dec 2023, 16:52
PTCT PTC THERAPEUTICS, INC. 13 Jul 2023 2 $0 4 CHIEF FINANCIAL OFFICER 17 Jul 2023, 16:51
PTCT PTC THERAPEUTICS, INC. 13 Jul 2023 0 $0 3 CHIEF FINANCIAL OFFICER 17 Jul 2023, 16:49